
Penumbra (PEN) Stock Forecast & Price Target
Penumbra (PEN) Analyst Ratings
Bulls say
Penumbra is positioned for strong financial performance, with expectations for annual revenue growth of 21% or more, driven by innovative new products and improved profitability. The company is likely to enhance both gross and operating margins, leading to earnings per share (EPS) growth that outpaces revenue growth. Market dynamics, including a potential increase in thrombectomy referrals and favorable international expansion, further support a positive outlook for the firm.
Bears say
The analysis indicates that Penumbra's projected revenue growth is anticipated to fall to 14% or less, largely due to disappointing contributions from new products and underwhelming profitability improvements. Additionally, the company faces significant risks from heightened competition, potential delays in product clearances, and regulatory hurdles, which could adversely affect its market share and margins. Finally, contrasting valuation metrics highlight concerns; Penumbra trades at an elevated EV/sales multiple compared to its peers, further exacerbating the perceived risk associated with its stock.
This aggregate rating is based on analysts' research of Penumbra and is not a guaranteed prediction by Public.com or investment advice.
Penumbra (PEN) Analyst Forecast & Price Prediction
Start investing in Penumbra (PEN)
Order type
Buy in
Order amount
Est. shares
0 shares